Fred Alger Management »

Ligand Pharmaceuticals In shares owned by Fred Alger Management

Quarter-by-quarter ownership of Ligand Pharmaceuticals In (LGND) shares owned by Fred Alger Management from 13F filings

Historical chart of Fred Alger Management investment in Ligand Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Ligand Pharmaceuticals In held by Fred Alger Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ligand Pharmaceuticals In by Fred Alger Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.0M 5.9k 177.14
2018-06-30 $207k 1.0k 207.00

More positions owned by Fred Alger Management

NVIDIA Corporation Equity (NVDA)
Microsoft Corporation Equity (MSFT)
Meta Platforms Inc Class A Equity (META)
Amazon.com Equity (AMZN)
AppLovin Corp. Class A Equity (APP)
Nebius Group N.V. Class A Equity (NBIS)
Apple Equity (AAPL)
Broadcom Equity (AVGO)
Alphabet Inc. Class C Equity (GOOG)
Talen Energy Corp Equity (TLN)
Tesla Equity (TSLA)
Sea Limited Sponsored ADR Class A Equity (SE)
Netflix Equity (NFLX)
Western Digital Corporation Equity (WDC)
Natera Equity (NTRA)

View all positions for Fred Alger Management

Top funds holding Ligand Pharmaceuticals In

BlackRock
Vanguard Group
Henderson Group
State Street Corporation
Chicago Capital
Invesco
Massachusetts Financial Services
Stephens Investment Management Group
Franklin Resources
Geode Capital Management
Congress Asset Management
FMR
Dimensional Fund Advisors
Goldman Sachs Group
Loomis, Sayles and

View all funds holding Ligand Pharmaceuticals In